|
Unite and align
|
3 |
Design universally accepted policies and interventions to improve access to appropriate care, including specialty care and services |
|
Reduce risk
|
4 |
Identify optimum timing of type of procedural medical intervention to inform treatment decisions in infancy, childhood, and adulthood |
5 |
Research to identify strategies to reduce cardiac and noncardiac morbidity, including the brain, lungs, liver, and kidneys |
6 |
Initiate practical, effective, and sustainable interventions for known modifiable risk factors for congenital heart disease that have public health importance (eg, maternal pregestational diabetes mellitus) |
|
Improve outcomes
|
7 |
Improve access to special education and/or other school‐based interventions for all children with congenital heart disease who have a neurodevelopmental impairment |
8 |
Develop formal transition programs between pediatric and adult care and ongoing monitoring to assess the success or obstacles to transition efforts |
9 |
Initiate programs to assure adequate support services for adults with neurocognitive decline |
|
Equal access
|
10 |
Encourage insurance availability for congenital heart disease care across the life span, including specialty care when necessary |
11 |
Develop programs to assure that all people with congenital heart disease have primary care in a patient‐centered medical home that includes supports to family members and caregivers |